PRODUCT NEWS: JULY 2013
Get a sneek peek at some products that will be unveiled at the 2013 AACC Expo.
Read More
Search Results for: prostate cancer
Strand Diagnostics, Manhattan Labs Partner to Create myPAP test
DNA confirmation ensures accurate patient identification of cervical cancer test specimen.
Read MoreGenomeDx’s Decipher Edges Out Current Risk Assessment Tools in Predicting Metastatic Prostate Cancer, Study Shows
Decipher is a genomic test that provides a readout of the risk of metastatic disease for individual men with prostate cancer following radical prostatectomy that is independent of PSA and other risk factors.
Read More
PRODUCT SPOTLIGHT: May 2013: Anatomic Pathology
The array of products ranges from mouse monoclonal antibodies to pathology information systems.
Read More
bioTheranostics’ Prostate Cancer Index Predicts Risk for Prostate Cancer Recurrence
Study demonstrates clinical validity of new molecular test, which stratifies risk of PSA recurrence and metastasis.
Read More